Joshua Dennerlein
Stock Analyst at B of A Securities
(2.17)
# 2,719
Out of 4,734 analysts
87
Total ratings
44.07%
Success rate
-4.95%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SUI Sun Communities | Downgrades: Underperform | $147 → $114 | $128.04 | -10.97% | 2 | Nov 12, 2024 | |
| FVR FrontView REIT | Initiates: Buy | $22 | $18.15 | +21.21% | 1 | Oct 28, 2024 | |
| GTY Getty Realty | Upgrades: Buy | $31 → $34 | $31.29 | +8.66% | 3 | Oct 21, 2024 | |
| AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $27.93 | +10.99% | 2 | Sep 24, 2024 | |
| NHI National Health Investors | Initiates: Buy | $92 | $70.36 | +30.76% | 1 | Sep 24, 2024 | |
| ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $285.24 | +12.54% | 3 | Sep 24, 2024 | |
| LINE Lineage | Initiates: Buy | $100 | $60.11 | +66.36% | 1 | Aug 19, 2024 | |
| CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $112.77 | +30.35% | 4 | Aug 12, 2024 | |
| MAA Mid-America Apartment Communities | Upgrades: Buy | $144 → $189 | $150.51 | +25.57% | 3 | Aug 12, 2024 | |
| EPR EPR Properties | Downgrades: Underperform | $45 → $40 | $47.60 | -15.97% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $21.12 | +18.37% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $37.68 | -17.73% | 11 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $60.29 | -12.09% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $9.22 | -34.92% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $41.31 | -20.12% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $14.75 | +1.69% | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $55.26 | -5.90% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $17.05 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $56.87 | -5.05% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.33 | +84.76% | 9 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $11.24 | +140.21% | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $22.29 | +50.29% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.05 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $73.17 | +6.60% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $40.57 | +15.85% | 2 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $73 → $78 | $133.67 | -41.65% | 5 | Mar 30, 2021 |
Sun Communities
Nov 12, 2024
Downgrades: Underperform
Price Target: $147 → $114
Current: $128.04
Upside: -10.97%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $18.15
Upside: +21.21%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $31.29
Upside: +8.66%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $27.93
Upside: +10.99%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $70.36
Upside: +30.76%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $285.24
Upside: +12.54%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $60.11
Upside: +66.36%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $112.77
Upside: +30.35%
Mid-America Apartment Communities
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $150.51
Upside: +25.57%
EPR Properties
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $47.60
Upside: -15.97%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $21.12
Upside: +18.37%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $37.68
Upside: -17.73%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $60.29
Upside: -12.09%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $9.22
Upside: -34.92%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $41.31
Upside: -20.12%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $14.75
Upside: +1.69%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $55.26
Upside: -5.90%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $17.05
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $56.87
Upside: -5.05%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.33
Upside: +84.76%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $11.24
Upside: +140.21%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $22.29
Upside: +50.29%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $32.05
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $73.17
Upside: +6.60%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $40.57
Upside: +15.85%
Mar 30, 2021
Upgrades: Buy
Price Target: $73 → $78
Current: $133.67
Upside: -41.65%